Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Aug;15(8):1145-50.
doi: 10.1128/CVI.00058-08. Epub 2008 Jun 18.

Biological activities of anti-merozoite surface protein-1 antibodies induced by adjuvant-assisted immunizations in mice with different immune gene knockouts

Affiliations

Biological activities of anti-merozoite surface protein-1 antibodies induced by adjuvant-assisted immunizations in mice with different immune gene knockouts

George Hui et al. Clin Vaccine Immunol. 2008 Aug.

Abstract

Immunizations with Plasmodium falciparum MSP1-42 or MSP1-19 induce antibodies that inhibit parasites in vitro, which correlates with in vivo protective immunity by vaccination. We previously showed that several adjuvant formulations can induce anti-MSP1-19 antibodies in interleukin-6, intercellular adhesion molecule 1, CD80, and CD86 knockout (KO) mice and at levels similar to those obtained in the healthy uninfected hosts. Here, we determine whether these immune gene KOs or the immunopotentiating activities of the adjuvants have a more important influence on the induction of parasite-inhibitory anti-MSP1-19 antibodies. Results showed that the biological activities of the anti-MSP1-19 antibodies induced by these adjuvants were not affected by the immune gene KOs. All adjuvant formulations that induced significant inhibitory antibody responses (i.e., >50% inhibition of parasite growth) contained monophosphoryl lipid A (MPL) in emulsion carriers, whereas MPL or emulsion carriers alone were ineffective. The ability to retain vaccine efficacy by the MSP1-19 and adjuvant formulations in the altered immunological background is a valuable and significant attribute in light of many instances of skewed immune status in the targeted vaccine populations.

PubMed Disclaimer

Figures

FIG. 1.
FIG. 1.
Relationship between ELISA anti-MSP1-19 titer and the degree of parasite growth inhibition of anti-MSP1-19 antibodies induced by different adjuvant formulations in WT, IL-6 KO, CD80 KO, CD86 KO, and ICAM-1 KO mice. Data are segregated into two groups represented by filled circles and open circles having parasite growth inhibition of >50% and <50%, respectively. Antibodies induced by the adjuvants ISA720-MPL, ISA720-QS21-MPL, and MPL-SE (filled circles) and antibodies induced by the adjuvants ISA720, MF59, QS21, ISA720-QS21, and MPL-AF (open circles) are shown. Regression lines (solid lines) for each of the two groups of data are shown with 95% confidence limits (dashed lines). A regression line (dotted pattern) for the entire combined data set is also shown.

Similar articles

Cited by

References

    1. Agrawal, A., J. Lingappa, S. H. Leppla, S. Agrawal, A. Jabbar, C. Quinn, and B. Pulendran. 2003. Impairment of dendritic cells and adaptive immunity by anthrax lethal toxin. Nature 424:329-334. - PubMed
    1. Angov, E., E. S. Bergman-Leitner, E. H. Duncan, A. Brent-Kirk, M. McCasland, R. Mease, L. Soisson, M.-A. Demoitie, B. R. Ogutu, D. G. Heppner, and J. A. Lyon. 2007. Measurement of antibody fine specificities induced by malaria vaccine FMP1/ASO2A from a pediatric phase 2B trial in western Kenya. Am. J. Trop. Med. Hyg., vol. 77, issue 5 (Suppl.), abstr. 12.
    1. Brady, C. P., R. L. Shimp, A. P. Miles, M. Whitmore, and A. W. Stowers. 2001. High-level production and purification of P30P2MSP1(19), an important vaccine antigen for malaria, expressed in the methylotropic yeast Pichia pastoris. Protein Expr. Purif. 23:468-475. - PubMed
    1. Chang, S. P., S. E. Case, W. L. Gosnell, A. Hashimoto, K. J. Kramer, L. Q. Tam, C. Q. Hashiro, C. M. Nikaido, H. L. Gibson, C. T. Lee-Ng, P. J. Barr, B. T. Yokota, and G. S. Hut. 1996. A recombinant baculovirus 42-kilodalton C-terminal fragment of Plasmodium falciparum merozoite surface protein 1 protects Aotus monkeys against malaria. Infect. Immun. 64:253-261. - PMC - PubMed
    1. Chang, S. P., H. L. Gibson, C. T. Lee-Ng, P. J. Barr, and G. S. Hui. 1992. A carboxyl-terminal fragment of Plasmodium falciparum gp195 expressed by a recombinant baculovirus induces antibodies that completely inhibit parasite growth. J. Immunol. 149:548-555. - PubMed

Publication types

MeSH terms